Developing a vaccine to target multiple proteins involved in Alzheimer's disease
Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes
This study is working on a new vaccine that could help fight Alzheimer's disease by training the immune system to target specific proteins linked to the condition, and it's being tested in mice that have a similar brain setup to humans, with hopes that it could lead to better treatments for people with Alzheimer's.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pop Biotechnologies, INC NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10929380 on NIH RePORTER |
What this research studies
This research aims to create a novel vaccine that targets multiple proteins associated with Alzheimer's disease, specifically Aβ and tau. By using a unique platform called SNAP liposomes, the project seeks to stimulate the immune system to effectively combat the disease. The approach involves testing this multivalent vaccine in a transgenic mouse model that mimics human Alzheimer's pathology, with the goal of finding a more effective treatment strategy. Patients may benefit from this research as it explores a new way to prevent or delay the progression of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease or those in the early stages of the condition.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any familial or genetic predisposition to the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking vaccine that significantly slows or prevents the onset of Alzheimer's disease.
How similar studies have performed: While there have been various immunotherapy approaches for Alzheimer's, this specific multivalent strategy is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
Buffalo, United States
- Pop Biotechnologies, INC — Buffalo, United States (Active)
Researchers
- Principal investigator: Huang, Wei-Chiao — Pop Biotechnologies, INC
- Study coordinator: Huang, Wei-Chiao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.